51 related articles for article (PubMed ID: 15988399)
1. CYP3A and drug interactions.
Med Lett Drugs Ther; 2005 Jul; 47(1212):54-5. PubMed ID: 15988399
[No Abstract] [Full Text] [Related]
2. Oral erythromycin and the risk of sudden death.
Kaplan EL
N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15659735
[No Abstract] [Full Text] [Related]
3. Oral erythromycin and the risk of sudden death.
Amory JK; Amory DW
N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
[No Abstract] [Full Text] [Related]
4. Combining erythromycin with other drugs may lead to sudden death.
Mayo Clin Womens Healthsource; 2005 Mar; 9(3):3. PubMed ID: 15689849
[No Abstract] [Full Text] [Related]
5. Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs.
AIDS Treat News; 2004 Sep; (405):6. PubMed ID: 15595151
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism of the expression and modulation of CYP3A gene].
Wang JS; Zhou HH
Sheng Li Ke Xue Jin Zhan; 1998 Apr; 29(2):173-6. PubMed ID: 12501692
[No Abstract] [Full Text] [Related]
7. Risperidone-carbamazepine interactions: is cytochrome P450 3A involved?
Lane HY; Chang WH
J Clin Psychiatry; 1998 Aug; 59(8):430-1. PubMed ID: 9721825
[No Abstract] [Full Text] [Related]
8. Cytochromes in psychopharmacology.
von Moltke LL; Greenblatt DJ; Harmatz JS; Shader RI
J Clin Psychopharmacol; 1994 Feb; 14(1):1-4. PubMed ID: 8150999
[No Abstract] [Full Text] [Related]
9. CYP3A genetics in drug metabolism.
Eichelbaum M; Burk O
Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
[No Abstract] [Full Text] [Related]
10. Cisapride (Prepulsid): interactions with grapefruit and drugs.
Morawiecka I
CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
[No Abstract] [Full Text] [Related]
11. Cytochrome P-450 3A: interactions with dermatologic therapies.
Singer MI; Shapiro LE; Shear NH
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):765-71. PubMed ID: 9366824
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity.
Hidaka M; Fujita K; Ogikubo T; Yamasaki K; Iwakiri T; Okumura M; Kodama H; Arimori K
Drug Metab Dispos; 2004 Jun; 32(6):581-3. PubMed ID: 15155547
[TBL] [Abstract][Full Text] [Related]
13. On the assessment of effects of food on the pharmacokinetics of drugs in early development.
Li Z; Vachharajani NN; Krishna R
Biopharm Drug Dispos; 2002 May; 23(4):165-71. PubMed ID: 12015791
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology.
Sagir A; Schmitt M; Dilger K; Häussinger D
Digestion; 2003; 68(1):41-8. PubMed ID: 12949438
[TBL] [Abstract][Full Text] [Related]
15. Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1.
Anzenbacherová E; Baranová J; Zuber R; Pechová A; Anzenbacher P; Soucek P; Martínková J
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):244-5. PubMed ID: 15733222
[No Abstract] [Full Text] [Related]
16. Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies.
Greenblatt DJ; von Moltke LL; Schmider J; Harmatz JS; Shader RI
J Clin Pharmacol; 1996 Sep; 36(9):792-8. PubMed ID: 8889899
[No Abstract] [Full Text] [Related]
17. Simultaneous itraconazole bioequivalence assessment and CYP3A phenotyping in South American subjects.
Estevez-Carrizo FE; Ruiz S; Bellocq B; Leal C; Siri MT; del Campo MJ
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):109-16. PubMed ID: 15726880
[TBL] [Abstract][Full Text] [Related]
18. Oral erythromycin and the risk of sudden death from cardiac causes.
Ray WA; Murray KT; Meredith S; Narasimhulu SS; Hall K; Stein CM
N Engl J Med; 2004 Sep; 351(11):1089-96. PubMed ID: 15356306
[TBL] [Abstract][Full Text] [Related]
19. Risperidone and cytochrome P450 3A.
de Leon J; Bork J
J Clin Psychiatry; 1997 Oct; 58(10):450. PubMed ID: 9375597
[No Abstract] [Full Text] [Related]
20. Current bioequivalence criteria are adequate for oral cyclosporin A formulations.
Castañeda-Hernández G; Pérez-Urizar J; Medeiros M
Ther Drug Monit; 1998 Dec; 20(6):722-3. PubMed ID: 9853995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
